2017, Number 4
<< Back Next >>
Arch Neurocien 2017; 22 (4)
Spinal cord ependymomas: evolution and prognosis
Amaya-Mejía J, Arriada-Mendicoa JN
Language: Spanish
References: 9
Page: 20-25
PDF size: 279.35 Kb.
ABSTRACT
The research aims to assess the functional state of the postsurgical patients who
underwent resection of ependymomas spinal cord, in the period from 2011 to 2015.
In Mexico, the epidemiology of spinal cord ependymomas is uncertain and even
more depending on the histological characterization based on the histological type,
site anatomical or the degree of tumor resection. The comprehensive diagnostic
assessment of these patients is performed at the National Institute of Neurology
and Neurosurgery, what is important, not only establish an epidemiological
database, aware of the prevalence of the ependymoma at institutional level,
but also check the neurological function of the patient involved, contrasting its
evolution from the initial evaluation, until his recovery rehabilitation after surgery.
REFERENCES
1.Yimo Lin Zas, Wong Albert P. Predictors of survival in patients with spinal ependymoma. Neurological Res 2015;37(7):650-5.
2.Aguirre-Cruz Lucinda, de la Cruz-Aguilera DL. Historical distribution of central nervous system tumors in the Mexican National Institute of Neurology and Neurosurgery. Salud Pub Méx 2016;58(2):171-8.
3.Azize Bostrom M, Marec von Lehe, Wolfgang Hartmann, Torsten Pietsch. Surgery for spinal cord ependymomas: outcome and prognostic factors. Neurosurgery 2011;68(2):302-9.
4.Karikari Mea Isaac O. Impact of tumor histology on resecctability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurg 2010;68(1):188-97.
5.Huanga Yu-Hua, Linb Jui-Wei. Managment and outcome of primary spinal ependymomas: a single center experience from Taiwan. Clin Neurol Neurosurg 2013;115:2130-5.
6.Dorfer Christian JT, Rutka James T. Handbook of clinical neurology: ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options. Elsevier 2016.
7.Klekamp Jorg M. Spinal ependymomas. Intramedullary ependymomas. Neurosurgical Focus 2015;39:2.
8.Kalil G, Abdullah Dlb, Jacob Miller C, Michael P, Steinmetz D, Shin John H, et al. Progression free survival and functional outcome after surgical resection of intramedullary ependymomas. J Clin Neuroscien 2015;22:1933-7.
9.Network NCC. Central nervous system cancer. NCCN Guidelines 2015;1.
Full text